Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

Lucile Vanhersecke(Université de Bordeaux), Maxime Brunet(Université de Bordeaux), Jean‐Philippe Guégan, Christophe Rey, Antoine Bougoüin(Inserm), Sophie Cousin(Institut Bergonié), Sylvestre Le Moulec(Clinique du Sport), Benjamin Besse(Institut Gustave Roussy), Yohann Loriot(Institut Gustave Roussy), Mathieu Larroquette(Université de Bordeaux), Isabelle Soubeyran(Institut Bergonié), Maud Toulmonde(Institut Bergonié), Guilhem Roubaud(Institut Bergonié), Simon Pernot(Institut Bergonié), Mathilde Cabart(Institut Bergonié), François Chomy(Institut Bergonié), Corentin Lefevre(Institut Bergonié), Kévin Bourcier(Institut Bergonié), Michèle Kind(Institut Bergonié), Ilenia Giglioli(Inserm), Catherine Sautès‐Fridman(Inserm), Valérie Velasco(Institut Bergonié), Félicie Courgeon, Ezoglin Oflazoglu(Merck Institute for Science Education), Ariel Savina(Merck Institute for Science Education), Aurélien Marabelle(Institut Gustave Roussy), Jean‐Charles Soria(Institut Gustave Roussy), Carine Bellera(Bordeaux Population Health), Casimir Ledoux Sofeu(Institut Bergonié), Alban Bessede, Wolf H. Fridman(Inserm), François Le Loarer(Université de Bordeaux), Antoîne Italiano(Université de Bordeaux)
Nature Cancer
August 12, 2021
Cited by 564Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis